Midface Volume Deficit
8
0
1
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
43%
3 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (8)
A Post-market-clinical Follow-up Investigation of Safety and Performance by Decoria® Voluma
Efficacy and Safety of Rejuviel V in the Correction of Midface Volume Deficit
Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency
To Evaluate the Performance and Safety of YVOIRE Volume Plus for Improvement of Mid-face Volume
A 52-week Clinical Investigation of Princess® VOLUME PLUS Lidocaine in Subjects With Midface Volume Deficit
Restylane Perlane Lidocaine for Correction of Midface Volume Deficit and/or Midface Contour Deficiency
Restylane Volyme for Correction of Midface Volume Deficit and/or Midface Contour Deficiency
Evaluation of the Safety and Performance of an Injectable Hyaluronic Acid Filler